Event Details
Service improvement workshop in MHID & CAMHS ID: service self-evaluation and appropriate prescribing
Date: Thursday 8th June 2023
Venue: Ashling Hotel Dublin 8 & Online
Organisers: Dr Louise Sharkey & Dr Evan Yacoub, Clinical Leads for CAMHS ID and MHID. HSE Mental Health Services.
CPD: Approved for 4.5 External / Internal Credits by CPsychI
Registration: Book here
A training workshop focusing on MHID/CAMHS ID service development. In particular it will address:
• Psychosocial factors leading to referrals and requests for psychotropic medication and contributing to polypharmacy in MHID/CAMHS ID • Best evidence for prescribing psychotropics for children and adults with intellectual disability (and comorbid mental disorder) and evidence for rationalising their use
• HSE service developments taking place to address these factors
• The process of Mental Health Service self-evaluation
• Quality Improvement Science Provisional
Agenda:
09.45 -10.00 coffee
10.00 – 10.05 (opening Dr Louise Sharkey; Dr Evan Yacoub, Clinical leads for CAMHS ID and MHID)
10.05 – 10.45 Prof David Taylor, Director of Pharmacy and Pathology Maudsley Hospital & Professor of Psychopharmacology King’s College London – Good Prescribing Practice
10.45-11.25 Prof Rohit Shankar, Professor of Neuropsychiatry, University of Plymouth – Overprescribing in Individuals with and Intellectual Disability
11.25-12.00 Ciara Latimer and Gerry Maley HSE National Disability Operations – How Individuals with Disability are assessed for National Disability Placements
12.00-12.20 coffee
12.20 -1 pm Dr John Fitzsimons Consultant Paediatrician and Clinical Director Quality Improvement HSE – “Getting Better – using Quality improvement Science to improve outcomes in healthcare”
1pm – 1.15 Dr Louise Sharkey and Dr Evan Yacoub Consultant Psychiatrists and National Clinical Leads for CAMHS and AMHS ID – Service Self-Evaluation Tools
1.15 – 1.55 Prof Shoumi Deb Professor of Neuropsychiatry, Imperial College London. “The RCT-based evidence for the efficacy of psychotropics for people with neurodevelopmental disorders.”
1.55-2.25 Panel Discussion
2.25-2.30 closing Dr Louise Sharkey/ Dr Evan Yacoub